Curis
CRIS
#11016
Rank
โ‚น0.33 B
Marketcap
โ‚น137.97
Share price
-2.68%
Change (1 day)
-4.59%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -โ‚น2,165

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น2,265. In 2025 the company made an earnings per share (EPS) of -โ‚น2,265 an increase over its 2024 EPS that were of -โ‚น13,378.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น2,165-4.39%
2025-โ‚น2,265-83.07%
2024-โ‚น13,378-22.15%
2023-โ‚น17,184-26.17%
2022-โ‚น23,27422.3%
2021-โ‚น19,030-25.37%
2020-โ‚น25,501-30.93%
2019-โ‚น36,919-2.02%
2018-โ‚น37,680
2016-โ‚น85,637-10%
2015-โ‚น95,152138.1%
2014-โ‚น39,96440%
2013-โ‚น28,546-25%
2012-โ‚น38,06166.67%
2011-โ‚น22,836

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.65-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น338.74-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น34.25-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น297.83-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น405.35-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น479.57-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น16.18-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA